Table 4.
Five-Year Total, Annual Average Totala, and Average Annual Age-Adjusted Incidence Ratesb with 95% Confidence Intervals for Selected Non-Malignant Histologies by Sex, Age Groups, Race, and Hispanic Ethnicity, Histology, and Age at Diagnosis, CBTRUS Statistical Report: U.S. Cancer Statistics – NPCR and SEER, 2013-2017
| Group | Vestibular Schwannomac | Pituitary Adenomad | WHO Grade I Meningiomae | WHO Grade II Meningiomaf | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-Year total | Annual Average | Rate | 95% CI | 5-Year total | Annual Average | Rate | 95% CI | 5-Year total | Annual Average | Rate | 95% CI | 5-Year total | Annual Average | Rate | 95% CI | |
| Sex | ||||||||||||||||
| Male | 12,349 | 2,470 | 1.45 | 1.42-1.48 | 27,424 | 5,485 | 3.31 | 3.27-3.35 | 39,166 | 7,833 | 4.79 | 4.74-4.84 | 3,148 | 630 | 0.38 | 0.36-0.39 |
| Female | 14,039 | 2,808 | 1.53 | 1.50-1.55 | 33,206 | 6,641 | 3.99 | 3.95-4.04 | 110,469 | 22,094 | 11.37 | 11.31-11.44 | 4,505 | 901 | 0.49 | 0.47-0.50 |
| Age Groups | ||||||||||||||||
| 0-14 Years | 197 | 39 | 0.07 | 0.06-0.08 | 861 | 172 | 0.29 | 0.27-0.31 | 202 | 40 | 0.07 | 0.06-0.08 | 82 | 16 | 0.03 | 0.02-0.03 |
| 15-39 Years | 3,584 | 717 | 0.70 | 0.67-0.72 | 17,234 | 3,447 | 3.27 | 3.22-3.32 | 8,449 | 1,690 | 1.69 | 1.66-1.73 | 867 | 173 | 0.17 | 0.16-0.18 |
| 40-64 Years | 14,168 | 2,834 | 2.56 | 2.52-2.61 | 26,299 | 5,260 | 5.00 | 4.94-5.06 | 58,789 | 11,758 | 10.45 | 10.36-10.54 | 3,504 | 701 | 0.63 | 0.61-0.66 |
| 65+ Years | 8,439 | 1,688 | 3.53 | 3.45-3.60 | 16,236 | 3,247 | 6.92 | 6.81-7.02 | 82,195 | 16,439 | 35.57 | 35.32-35.81 | 3,200 | 640 | 1.37 | 1.33-1.42 |
| Race | ||||||||||||||||
| White | 22,745 | 4,549 | 1.58 | 1.56-1.60 | 43,492 | 8,698 | 3.25 | 3.22-3.29 | 121,777 | 24,355 | 8.11 | 8.06-8.15 | 5,969 | 1,194 | 0.41 | 0.40-0.42 |
| Black | 1,449 | 290 | 0.68 | 0.65-0.72 | 12,120 | 2,424 | 5.82 | 5.72-5.93 | 18,689 | 3,738 | 9.54 | 9.40-9.68 | 1,131 | 226 | 0.55 | 0.52-0.59 |
| American Indian/Alaska Native | 154 | 31 | 0.75 | 0.63-0.89 | 502 | 100 | 2.49 | 2.26-2.73 | 890 | 178 | 5.29 | 4.93-5.67 | 37 | 7 | 0.23 | 0.15-0.32 |
| Asian or Pacific Islander | 1,174 | 235 | 1.18 | 1.11-1.25 | 2,454 | 491 | 2.49 | 2.39-2.60 | 5,270 | 1,054 | 5.87 | 5.71-6.03 | 357 | 71 | 0.37 | 0.33-0.41 |
| Hispanic Ethnicity | ||||||||||||||||
| Non-Hispanic | 24,181 | 4,836 | 1.57 | 1.55-1.59 | 50,948 | 10,190 | 3.55 | 3.51-3.58 | 135,219 | 27,044 | 8.39 | 8.34-8.43 | 6,976 | 1,395 | 0.45 | 0.44-0.46 |
| Hispanic | 2,207 | 441 | 1.00 | 0.96-1.05 | 9,682 | 1,936 | 4.08 | 3.99-4.17 | 14,416 | 2,883 | 7.79 | 7.66-7.92 | 677 | 135 | 0.33 | 0.30-0.35 |
| TOTAL | 21,453 | 4,291 | 1.20 | 1.19-1.22 | 60,630 | 12,126 | 3.61 | 3.58-3.64 | 149,635 | 29,927 | 8.29 | 8.24-8.33 | 7,653 | 1,531 | 0.43 | 0.42-0.44 |
a. Annual average cases are calculated by dividing the five year total by five.
b. Rates are per 100,000 and are age-adjusted to the 2000 US standard population.
c. ICD-O-3 histology code 9560/0 and ICD-O-3 topography code C72.4 and C72.5.
d. ICD-O-3 histology code 8272/0 and ICD-O-3 topography code C75.1.
e. ICD-O-3 histology codes 9530/0, 9531/0, 9532/0, 9533/0, 9534/0, and 9537/0.
f. ICD-O-3 histology codes 9530/1, 9531/1, 9532/1, 9533/1, 9534/1, 9537/1, 9538/1, and 9539/1.
- Counts and rates are not presented when fewer than 16 cases were reported for the specific category. The suppressed cases are included in the counts and rates for totals.
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results Program; CI, confidence interval